Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Saccharomyces Cerevisiae
Therapeutic Area : Gastroenterology
Study Phase : Phase I/ Phase II
Recipient : Ziauddin University
Deal Size : Inapplicable
Deal Type : Inapplicable
Saccharomyces Cerevisiae for Irritable Bowel Syndrome
Details : Saccharomyces Cerevisiae is a Probiotic drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Irritable Bowel Syndrome.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
December 08, 2021
Lead Product(s) : Saccharomyces Cerevisiae
Therapeutic Area : Gastroenterology
Highest Development Status : Phase I/ Phase II
Recipient : Ziauddin University
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
